Skip to content

Diasorin

Active
Public limited companyfounded 199629 yrs activePaapsemlaan 11, 1070 Anderlecht, BelgiumKBO/BCE: BE 0459.475.142
Summary

Diasorin has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.8m and a net result of €2.4m. Equity remains stable across the filed fiscal years (±1.4% per year). Its solvency ranks better than 20% of 646 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability71▼-11
Solvency41▼-23
Growth37▼-15
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €160,000 at 30 days acceptable
Liquidity short (current ratio 0.91 against 1.31 in 2024; short-term debt: 81.4% and cash: 0% of total assets), and 84.4% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 29 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
15.6%
Return on assets
13.1%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 646 sector peers (2025).
NBB · sector comparison
Position among 646 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-04-2026, 106 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
106 d early
2024
222 d late
2023
103 d early
2022
76 d early
2021
76 d early
2020
87 d early
2019
78 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 43 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 16 May (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Diasorin was incorporated on 17 December 1996.1 In 2023 the company took the name Diasorin.2 The board currently has 3 members; Barbara Rocchi has served longest, since 2024.3 Revenue grew from EUR 24 million in 2018 to EUR 32 million in 2025 and headcount from 28.4 to 23.9 full-time equivalents.4

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 18-10-2023
  3. 3Belgian State Gazette, 30-05-2024
  4. 4National Bank, annual accounts 2018 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€32.0m▼ 2.3%
2024 · €32.7m
EBIT margin
10.5%▼ 0.5pp
2024 · 10.9%
Net result
€2.4m▼ 12.4%
2024 · €2.7m
Working capital
-€1.3m
2024 · €3.5m
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€30.6m▲ 10.5%€29.5m▼ 3.6%€30.8m▲ 4.5%€32.7m▲ 6.1%€32.0m▼ 2.3%
Operating result€3.8m▲ 1.4%€3.2m▼ 16.0%€2.8m▼ 13.8%€3.6m▲ 29.2%€3.3m▼ 6.5%
Net result€2.9mabove the sector's middle half▲ 3.9%€2.4mabove the sector's middle half▼ 19.2%€2.0mabove the sector's middle half▼ 13.5%€2.7mabove the sector's middle half▲ 32.2%€2.4mabove the sector's middle half▼ 12.4%
EBIT margin12.5%▼ 1.1pp10.9%▼ 1.6pp9.0%▼ 1.9pp10.9%▲ 2.0pp10.5%▼ 0.5pp
Equity€8.5mabove the sector's middle half▲ 52.3%€8.5mabove the sector's middle half▲ 0.1%€8.0mabove the sector's middle half▼ 5.4%€7.7mabove the sector's middle half▼ 3.8%€2.8mabove the sector's middle half▼ 63.8%
Total assets€16.9mabove the sector's middle half▲ 4.2%€18.6mabove the sector's middle half▲ 9.9%€19.7mabove the sector's middle half▲ 6.1%€19.7mabove the sector's middle half▼ 0.1%€17.9mabove the sector's middle half▼ 8.9%
Debt€8.4m▼ 21.0%€10.1m▲ 19.8%€11.5m▲ 13.8%€12.0m▲ 4.2%€15.2m▲ 26.6%
Working capital€6.3mabove the sector's middle half▲ 99.7%€2.9mabove the sector's middle half▼ 54.1%€3.6mabove the sector's middle half▲ 24.3%€3.5mabove the sector's middle half▼ 3.8%-€1.3mbelow the sector's middle half
Solvency50.2%within the sector's middle half▲ 15.9pp45.8%within the sector's middle half▼ 4.5pp40.8%within the sector's middle half▼ 5.0pp39.3%within the sector's middle half▼ 1.5pp15.6%below the sector's middle half▼ 23.7pp
Current ratio1.77within the sector's middle half▲ 0.471.30within the sector's middle half▼ 0.471.33within the sector's middle half▲ 0.031.31within the sector's middle half▼ 0.020.91below the sector's middle half▼ 0.40
Return on assets (ROA)17.3%within the sector's middle half▼ 0.1pp12.7%within the sector's middle half▼ 4.6pp10.3%within the sector's middle half▼ 2.3pp13.7%within the sector's middle half▲ 3.3pp13.1%within the sector's middle half▼ 0.5pp
Staff (FTE)28.6above the sector's middle half▼ 4.0%62.4above the sector's middle half▲ 118%24.9above the sector's middle half▼ 60.1%21.4above the sector's middle half▼ 14.1%23.9above the sector's middle half▲ 11.7%
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
€0€1.0m€2.0m€3.0m€4.0mOperating result 2021: €3.8m€3.8mNet result 2021: €2.9m€2.9mOperating result 2022: €3.2m€3.2mNet result 2022: €2.4m€2.4mOperating result 2023: €2.8m€2.8mNet result 2023: €2.0m€2.0mOperating result 2024: €3.6m€3.6mNet result 2024: €2.7m€2.7mOperating result 2025: €3.3m€3.3mNet result 2025: €2.4m€2.4m20212022202320242025€0€1m€2m€3m€4mOperating result 2023: €2.8m€2.8mNet result 2023: €2.0m€2mOperating result 2024: €3.6m€3.6mNet result 2024: €2.7m€2.7mOperating result 2025: €3.3m€3.3mNet result 2025: €2.4m€2.4m202320242025
The operating result falls in 2025; 2025 is 7% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €17.9m
Fixed assets €4.6m ▼ 10.0%
Current assets €13.3m ▼ 8.5%
Equity and liabilities €17.9m
Equity €2.8m ▼ 63.8%
Debt €15.2m ▲ 26.6%
Debt's share of the balance-sheet total rises from 60.7% to 84.4%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€4.1m▼
2024 · €4.4m
Cash flow
€3.2m▼
2024 · €3.6m
Quick ratio
0.84▼
2024 · 1.22
Debt to equity
5.41▲
2024 · 1.55
ROE
84.3%▲
2024 · 34.8%
Debt ≤ 1 year
€14.6m▲
2024 · €11.1m
Debt > 1 year
€0
Income taxes
€952,892▲
2024 · €921,980
Staff costs
€5.0m▼
2024 · €5.4m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,613 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Small
  • 20 years or older
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.0% stopped otherwise
97% still going

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,613 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 144 lines
Balance sheet Code20242025
Assets
Total assets20/58€19.7m€17.9m▼
Formation expenses20-€0
Fixed assets21/28€5.1m€4.6m▼
Intangible fixed assets21€3.3m€2.9m▼
Tangible fixed assets22/27€1.1m€1.0m▼
Land and buildings22-€0
Plant, machinery and equipment23€676,813€535,682▼
Furniture and vehicles24€71,436€68,639▼
Leasing and similar rights25-€0
Other tangible fixed assets26€394,348€420,978▲
Assets under construction and advance payments27-€0
Financial fixed assets28€631,303€631,303=
Affiliated companies280/1-€0
Participating interests280-€0
Amounts receivable281-€0
Companies linked by participating interests282/3-€0
Participating interests282-€0
Amounts receivable283-€0
Other financial fixed assets284/8€631,303€631,303=
Shares284-€0
Amounts receivable and cash guarantees285/8€631,303€631,303=
Current assets29/58€14.6m€13.3m▼
Amounts receivable after more than one year29-€0
Trade receivables290-€0
Other amounts receivable291-€0
Stocks and contracts in progress3€1.1m€1.1m▲
Stocks30/36€1.1m€1.1m▲
Raw materials and consumables30/31-€0
Work in progress32-€0
Finished goods33-€0
Goods purchased for resale34€1.1m€1.1m▲
Property held for sale35-€0
Advance payments36-€0
Contracts in progress37-€0
Amounts receivable within one year40/41€13.4m€12.2m▼
Trade receivables40€8.0m€8.1m▲
Other amounts receivable41€5.3m€4.1m▼
Current investments50/53-€0
Own shares50-€0
Other investments51/53-€0
Cash at bank and in hand54/58€4,213€5,049▲
Deferred charges and accrued income490/1€131,498€95,219▼
Equity and liabilities
Total equity and liabilities10/49€19.7m€17.9m▼
Equity10/15€7.7m€2.8m▼
Contributions10/11€1.7m€1.7m=
Capital10€1.7m€1.7m=
Issued capital100€1.7m€1.7m=
Uncalled capital101-€0
Outside capital11-€0
Share premium1100/10-€0
Other1109/19-€0
Revaluation surpluses12-€0
Reserves13€167,400€167,400=
Non-distributable reserves130/1€167,400€167,400=
Legal reserve130€167,400€167,400=
Reserves not available under the articles1311-€0
Own shares acquired1312-€0
Financial assistance1313-€0
Other1319-€0
Tax-exempt reserves132-€0
Distributable reserves133-€0
Profit (loss) carried forward14€5.9m€957,603▼
Investment grants15-€0
Advance to shareholders on the distribution of net assets19-€0
Provisions and deferred taxes16-€0
Provisions for liabilities and charges160/5-€0
Pensions and similar obligations160-€0
Taxes161-€0
Major repairs and maintenance162-€0
Environmental obligations163-€0
Other liabilities and charges164/5-€0
Deferred taxes168-€0
Amounts payable17/49€12.0m€15.2m▲
Amounts payable after more than one year17-€0
Financial debts170/4-€0
Subordinated loans170-€0
Unsubordinated bonds171-€0
Leasing and similar obligations172-€0
Credit institutions173-€0
Other loans174-€0
Trade debts175-€0
Suppliers1750-€0
Bills of exchange payable1751-€0
Advances received on contracts in progress176-€0
Other amounts payable178/9-€0
Amounts payable within one year42/48€11.1m€14.6m▲
Current portion of amounts payable after more than one year42-€0
Financial debts43-€0
Credit institutions430/8-€0
Other loans439-€0
Trade debts44€6.2m€5.5m▼
Suppliers440/4€6.2m€5.5m▼
Bills of exchange payable441-€0
Advances received on contracts in progress46-€0
Taxes, remuneration and social security45€1.9m€1.7m▼
Taxes450/3€847,085€873,251▲
Remuneration and social security454/9€1.0m€844,125▼
Other amounts payable47/48€3.0m€7.4m▲
Accrued charges and deferred income492/3€857,495€544,075▼
Income statement Code20242025
Operating income70/76A€36.0m€34.2m▼
Turnover70€32.7m€32.0m▼
Change in stocks of work in progress, finished goods and contracts in progress71-€0
Own construction capitalised72-€0
Other operating income74€3.3m€2.3m▼
Non-recurring operating income76A-€0
Operating charges60/66A€32.4m€30.9m▼
Goods for resale, raw materials and consumables60€21.0m€20.5m▼
Purchases600/8€21.1m€20.6m▼
Change in stocks: decrease (increase)609-€98,359-€32,171▲
Services and other goods61€4.7m€4.2m▼
Remuneration, social security and pensions62€5.4m€5.0m▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€859,803€791,805▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€196,237€5,570▼
Provisions for liabilities and charges: additions (uses and reversals)635/8-€0
Other operating charges640/8€495,233€338,564▼
Non-recurring operating charges66A-€200,000€0▲
Operating profit (loss)9901€3.6m€3.3m▼
Financial income75/76B€115,494€37,552▼
Recurring financial income75€115,494€37,552▼
Income from financial fixed assets750-€0
Income from current assets751€59,732€37,552▼
Other financial income752/9€55,763€0▼
Non-recurring financial income76B-€0
Financial charges65/66B€71,240€64,840▼
Recurring financial charges65€71,240€64,840▼
Debt charges650-€0
Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651-€0
Other financial charges652/9€71,240€64,840▼
Non-recurring financial charges66B-€0
Profit (loss) for the period before taxes9903€3.6m€3.3m▼
Transfer from deferred taxes780-€0
Transfer to deferred taxes680-€0
Income taxes67/77€921,980€952,892▲
Taxes670/3€930,242€952,892▲
Tax adjustments and reversals of tax provisions77€8,262€0▼
Profit (loss) for the period9904€2.7m€2.4m▼
Transfer from tax-exempt reserves789-€0
Transfer to tax-exempt reserves689-€0
Profit (loss) for the period to be appropriated9905€2.7m€2.4m▼
Appropriation of the result
Profit (loss) to be appropriated9906€8.9m€8.3m▼
Profit (loss) brought forward from the previous period14P€6.2m€5.9m▼
Profit to be distributed694/7€3.0m€7.3m▲
Return on contributions (dividend)694€3.0m€7.3m▲
Social balance
Average headcount (FTE)908721.423.9▲

The notes to these accounts (74 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Operating income70/76A€30.8m€31.2m€34.1m€36.0m€34.2m▼ 4.9%
Turnover70€30.6m€29.5m€30.8m€32.7m€32.0m▼ 2.3%
Change in stocks of work in progress, finished goods and contracts in progress71----€0-
Own construction capitalised72----€0-
Other operating income74€250,853€1.7m€3.3m€3.3m€2.3m▼ 31.5%
Non-recurring operating income76A----€0-
Operating charges60/66A€27.0m€28.0m€31.4m€32.4m€30.9m▼ 4.8%
Goods for resale, raw materials and consumables60€21.6m€18.9m€19.8m€21.0m€20.5m▼ 2.0%
Purchases600/8€21.7m€19.4m€19.9m€21.1m€20.6m▼ 2.3%
Change in stocks: decrease (increase)609-€20,383-€409,973-€169,660-€98,359-€32,171▲ 67.3%
Services and other goods61€1.9m€2.9m€4.8m€4.7m€4.2m▼ 11.4%
Remuneration, social security and pensions62€2.7m€4.6m€5.5m€5.4m€5.0m▼ 6.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€608,938€819,567€958,774€859,803€791,805▼ 7.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€9,161€119,383€56,483€196,237€5,570▼ 97.2%
Provisions for liabilities and charges: additions (uses and reversals)635/8----€0-
Other operating charges640/8€121,277€588,445€136,067€495,233€338,564▼ 31.6%
Non-recurring operating charges66A--€200,000-€200,000€0▲ 100%
Operating profit (loss)9901€3.8m€3.2m€2.8m€3.6m€3.3m▼ 6.5%
Financial income75/76B€339€436€29,297€115,494€37,552▼ 67.5%
Recurring financial income75€339€436€29,297€115,494€37,552▼ 67.5%
Income from financial fixed assets750----€0-
Income from current assets751€283€236€0€59,732€37,552▼ 37.1%
Other financial income752/9€56€200€29,297€55,763€0▼ 100%
Non-recurring financial income76B----€0-
Financial charges65/66B€8,847€63,117€74,444€71,240€64,840▼ 9.0%
Recurring financial charges65€8,847€63,117€74,444€71,240€64,840▼ 9.0%
Debt charges650--€7,295-€0-
Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651----€0-
Other financial charges652/9€8,847€63,117€67,150€71,240€64,840▼ 9.0%
Non-recurring financial charges66B----€0-
Profit (loss) for the period before taxes9903€3.8m€3.1m€2.7m€3.6m€3.3m▼ 8.4%
Transfer from deferred taxes780----€0-
Transfer to deferred taxes680----€0-
Income taxes67/77€892,145€789,034€680,874€921,980€952,892▲ 3.4%
Taxes670/3€952,554€789,034€680,874€930,242€952,892▲ 2.4%
Tax adjustments and reversals of tax provisions77€60,409--€8,262€0▼ 100%
Profit (loss) for the period9904€2.9m€2.4m€2.0m€2.7m€2.4m▼ 12.4%
Transfer from tax-exempt reserves789----€0-
Transfer to tax-exempt reserves689----€0-
Profit (loss) for the period to be appropriated9905€2.9m€2.4m€2.0m€2.7m€2.4m▼ 12.4%
Line20212022202320242025Change
Assets
Total assets20/58€16.9m€18.6m€19.7m€19.7m€17.9m▼ 8.9%
Formation expenses20----€0-
Fixed assets21/28€2.3m€6.0m€5.3m€5.1m€4.6m▼ 10.0%
Intangible fixed assets21€637,156€4.2m€3.8m€3.3m€2.9m▼ 11.7%
Tangible fixed assets22/27€1.2m€1.3m€922,667€1.1m€1.0m▼ 10.3%
Land and buildings22----€0-
Plant, machinery and equipment23€1.0m€1.1m€759,083€676,813€535,682▼ 20.9%
Furniture and vehicles24€73,906€77,080€82,763€71,436€68,639▼ 3.9%
Leasing and similar rights25----€0-
Other tangible fixed assets26€93,513€97,012€80,821€394,348€420,978▲ 6.8%
Assets under construction and advance payments27----€0-
Financial fixed assets28€500,441€526,699€568,213€631,303€631,303=
Affiliated companies280/1----€0-
Participating interests280----€0-
Amounts receivable281----€0-
Companies linked by participating interests282/3----€0-
Participating interests282----€0-
Amounts receivable283----€0-
Other financial fixed assets284/8€500,441€526,699€568,213€631,303€631,303=
Shares284----€0-
Amounts receivable and cash guarantees285/8€500,441€526,699€568,213€631,303€631,303=
Current assets29/58€14.6m€12.6m€14.4m€14.6m€13.3m▼ 8.5%
Amounts receivable after more than one year29----€0-
Trade receivables290----€0-
Other amounts receivable291----€0-
Stocks and contracts in progress3€585,925€911,921€1.0m€1.1m€1.1m▲ 0.4%
Stocks30/36€585,925€911,921€1.0m€1.1m€1.1m▲ 0.4%
Raw materials and consumables30/31----€0-
Work in progress32----€0-
Finished goods33----€0-
Goods purchased for resale34€585,925€911,921€1.0m€1.1m€1.1m▲ 0.4%
Property held for sale35----€0-
Advance payments36----€0-
Contracts in progress37----€0-
Amounts receivable within one year40/41€14.0m€11.5m€13.3m€13.4m€12.2m▼ 9.1%
Trade receivables40€6.0m€8.0m€9.6m€8.0m€8.1m▲ 0.3%
Other amounts receivable41€8.0m€3.5m€3.7m€5.3m€4.1m▼ 23.1%
Current investments50/53----€0-
Own shares50----€0-
Other investments51/53----€0-
Cash at bank and in hand54/58-€3,097€0€4,213€5,049▲ 19.8%
Deferred charges and accrued income490/1€28,421€143,560€93,189€131,498€95,219▼ 27.6%
Equity and liabilities
Total equity and liabilities10/49€16.9m€18.6m€19.7m€19.7m€17.9m▼ 8.9%
Equity10/15€8.5m€8.5m€8.0m€7.7m€2.8m▼ 63.8%
Contributions10/11€1.7m€1.7m€1.7m€1.7m€1.7m=
Capital10€1.7m€1.7m€1.7m€1.7m€1.7m=
Issued capital100€1.7m€1.7m€1.7m€1.7m€1.7m=
Uncalled capital101----€0-
Outside capital11----€0-
Share premium1100/10----€0-
Other1109/19----€0-
Revaluation surpluses12----€0-
Reserves13€167,400€167,400€167,400€167,400€167,400=
Non-distributable reserves130/1€167,400€167,400€167,400€167,400€167,400=
Legal reserve130€167,400€167,400€167,400€167,400€167,400=
Reserves not available under the articles1311----€0-
Own shares acquired1312----€0-
Financial assistance1313----€0-
Other1319----€0-
Tax-exempt reserves132----€0-
Distributable reserves133----€0-
Profit (loss) carried forward14€6.7m€6.7m€6.2m€5.9m€957,603▼ 83.8%
Investment grants15----€0-
Advance to shareholders on the distribution of net assets19----€0-
Provisions and deferred taxes16--€200,000-€0-
Provisions for liabilities and charges160/5--€200,000-€0-
Pensions and similar obligations160----€0-
Taxes161----€0-
Major repairs and maintenance162----€0-
Environmental obligations163----€0-
Other liabilities and charges164/5--€200,000-€0-
Deferred taxes168----€0-
Amounts payable17/49€8.4m€10.1m€11.5m€12.0m€15.2m▲ 26.6%
Amounts payable after more than one year17----€0-
Financial debts170/4----€0-
Subordinated loans170----€0-
Unsubordinated bonds171----€0-
Leasing and similar obligations172----€0-
Credit institutions173----€0-
Other loans174----€0-
Trade debts175----€0-
Suppliers1750----€0-
Bills of exchange payable1751----€0-
Advances received on contracts in progress176----€0-
Other amounts payable178/9----€0-
Amounts payable within one year42/48€8.2m€9.7m€10.8m€11.1m€14.6m▲ 31.5%
Current portion of amounts payable after more than one year42----€0-
Financial debts43----€0-
Credit institutions430/8----€0-
Other loans439----€0-
Trade debts44€7.1m€5.0m€6.5m€6.2m€5.5m▼ 11.4%
Suppliers440/4€7.1m€5.0m€6.5m€6.2m€5.5m▼ 11.4%
Bills of exchange payable441----€0-
Advances received on contracts in progress46----€0-
Taxes, remuneration and social security45€1.1m€1.8m€1.8m€1.9m€1.7m▼ 8.5%
Taxes450/3€532,417€896,310€874,211€847,085€873,251▲ 3.1%
Remuneration and social security454/9€569,879€926,980€953,819€1.0m€844,125▼ 18.1%
Other amounts payable47/48-€2.8m€2.5m€3.0m€7.4m▲ 146%
Accrued charges and deferred income492/3€189,760€421,709€656,145€857,495€544,075▼ 36.6%
Line20212022202320242025Change
Profit (loss) for the period9904€2.9m€2.4m€2.0m€2.7m€2.4m▼ 12.4%
+ Depreciation and write-downs630€608,938€819,567€958,774€859,803€791,805▼ 7.9%
Operating cash flow (approximation)€3.5m€3.2m€3.0m€3.6m€3.2m▼ 11.3%
Investment in fixed assets (approximation)--€4.5m-€225,102-€695,068-€282,067▲ 59.4%
Change in cash---€3,097€4,213€836▼ 80.2%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
22-05
State Gazette act Resignation: Valerio Giovanni Vaccarone (director)
Appointment: Matteo Lombardi (director) · Director discharge10 facts ▸
  • General meeting, 07-05-2026
  • Director resignation, Valerio Giovanni Vaccarone (director)
  • Director discharge, Valerio Giovanni Vaccarone (director)
  • Director appointment, Matteo Lombardi (director)
  • Other statement, acceptation de nomination, accepte sa nomination en tant qu'administrateur conformément aux conditions susmentionnées en signant les présentes décisions
  • Other statement, aucune condamnation prononçant une interdiction équivalente rendue par une juridiction d'un État membre de l'Espace Économique Européen, absence d'interdiction…
  • Board composition, Barbara Rocchi (director)
  • Board composition, Romuald Courtade (director)
  • Board composition, Matteo Lombardi (director)
  • Other statement, signature de mandataire, Mandataire
24-04
State Gazette act Resignation: Jorge Cereijido Ferreira (director)
Appointment: Romuald Courtade (director) · Permanent representatives: Jorge Cereijido Ferreira and Romuald Courtade · Declaration15 facts ▸
  • Director resignation, Jorge Cereijido Ferreira (director)
  • Director appointment, Romuald Courtade (director)
  • Declaration, acceptation de la nomination en tant qu'administrateur, aucune condamnation prononçant une interdiction équivalente à l'une des interdictions visées à l'article…
  • Board composition, Valerio Giovanni Vaccarone (director)
  • Board composition, Barbara Rocchi (director)
  • Board composition, Romuald Courtade (director)
  • Director resignation, Jorge Cereijido Ferreira (managing director)
  • Power of attorney, Jorge Cereijido Ferreira
  • Permanent representative, Jorge Cereijido Ferreira (représentant permanent de la succursale néerlandaise)
  • Director appointment, Romuald Courtade (managing director)
  • Declaration, acceptation de la nomination en qualité d'administrateur délégué
  • Permanent representative, Romuald Courtade (représentant permanent de la succursale néerlandaise)
  • +3 further facts in this act
16-04
NBB filing Annual accounts filed
fiscal year 2025 · full schema
13-03
State Gazette act Reappointment: EY Réviseurs d'Entreprises SRL (statutory auditor)
Permanent representative: Thomas Meurice · Power of attorney · Auditor remuneration7 facts ▸
  • General meeting, 12-05-2025
  • Auditor reappointment, EY Réviseurs d'Entreprises SRL (statutory auditor)
  • Permanent representative, Thomas Meurice (permanent representative)
  • Power of attorney, Michel Bonne
  • Power of attorney, Jens Westerwoudt
  • Power of attorney, Aleksandrs Cerepanovs
  • Auditor remuneration, EUR 39.000
10-03
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 222 days late
15-01
State Gazette act Permanent representative: Halmar de Rooij
Power of attorney · Branch7 facts ▸
  • Board meeting, 18-12-2025
  • Permanent representative, Halmar de Rooij (représentant permanent de la succursale néerlandaise)
  • Power of attorney, Michel Bonne
  • Power of attorney, Jens Westerwoudt
  • Power of attorney, Aleksandrs Cerepanovs
  • Power of attorney, Brechje van Nes
  • Branch, DiaSorin SA/NV
2025
10-04
State Gazette act Resignations & appointments
Power of attorney7 facts ▸
  • Board meeting, 23-12-2024
  • Power of attorney, Georges Pazzaglia
  • Power of attorney, Damien Mannaert
  • Power of attorney, Teresa Cervino
  • Power of attorney, Fabrizio Momblano
  • Power of attorney, Fernando Ariel Davico
  • Power of attorney, Stephen Close Tomkins
01-04
State Gazette act Permanent representatives: Griet Helsen and Didier Delanoye
Power of attorney · Statutory auditor · Permanent representative replacement8 facts ▸
  • General meeting, 21-03-2025
  • Permanent representative, Griet Helsen
  • Permanent representative, Didier Delanoye
  • Power of attorney, Michel Bonne
  • Power of attorney, Jens Westerwoudt
  • Power of attorney, Aleksandrs Cerepanovs
  • Statutory auditor, commissaire
  • Permanent representative replacement, Griet Helsen BV remplace Didier Delanoye BV comme représentant de PwC dans son mandat de commissaire, à partir du 6 janvier 2025
2024
19-11
State Gazette act Permanent representative: Didier Delanoye
Power of attorney5 facts ▸
  • General meeting, 30-10-2024
  • Permanent representative, Didier Delanoye
  • Power of attorney, Michel Bonne
  • Power of attorney, Jens Westerwoudt
  • Power of attorney, Aleksandrs Cerepanovs
19-11
State Gazette act Resignations & appointments
Power of attorney3 facts ▸
  • Board meeting, 23-10-2024
  • Power of attorney, Jorge Cereijido Ferreira
  • Power of attorney, Jorge Cereijido Ferreira
30-05
State Gazette act Appointment: Barbara Rocchi (director)
Power of attorney8 facts ▸
  • General meeting, 15-05-2024
  • Director appointment, Barbara Rocchi (director)
  • Board composition, Valerio Giovanni Vaccarone (director)
  • Board composition, Jorge Cereijido Ferreira (director)
  • Board composition, Barbara Rocchi (director)
  • Power of attorney, Michel Bonne
  • Power of attorney, Jens Westerwoudt
  • Power of attorney, Viktor Francq
22-05
State Gazette act Resignation: Stephen Close Tomkins (director)
Power of attorney5 facts ▸
  • General meeting, 12-04-2024
  • Director resignation, Stephen Close Tomkins (director)
  • Board composition, Valerio Giovanni Vaccarone (director)
  • Board composition, Jorge Cereijido Ferreira (director)
  • Power of attorney, Van Bael & Bellis
Show earlier events
19-04
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Weakest financial yearnet €2.0m ▼13.5%
Net result drops to €2.0m, the lowest in the series; recovery starts the following year.
20-11
State Gazette act Resignation: Georges Pazzaglia (managing director)
Appointment: Jorge Cereijido Ferreira (managing director) · Permanent representatives: Jorge Cereijido Ferreira and Halmar De Rooij · Director discharge19 facts ▸
  • Board meeting, 24-10-2023
  • Director resignation, Georges Pazzaglia (managing director)
  • Director discharge, Georges Pazzaglia
  • Power of attorney, Georges Pazzaglia
  • Director resignation, Georges Pazzaglia (représentant permanent de la succursale néerlandaise)
  • Director discharge, Georges Pazzaglia
  • Director appointment, Jorge Cereijido Ferreira (managing director)
  • Mandate compensation, Jorge Cereijido Ferreira
  • Director appointment, Jorge Cereijido Ferreira (représentant permanent de la succursale néerlandaise)
  • Mandate compensation, Jorge Cereijido Ferreira
  • Power of attorney, Jorge Cereijido Ferreira
  • Permanent representative, Jorge Cereijido Ferreira (représentant permanent de la succursale néerlandaise)
  • +7 further facts in this act
18-10
State Gazette act Resignation: PAZZAGLIA Georges Léon (director)
Appointment: CEREIJIDO FERREIRA Jorge (director) · Name change · Statutes amendment10 facts ▸
  • General meeting, 05-10-2023
  • Name change, Diasorin
  • Statutes amendment
  • Capital, €1.674.000
  • Director resignation, PAZZAGLIA Georges Léon (director)
  • Director discharge, PAZZAGLIA Georges Léon
  • Director appointment, CEREIJIDO FERREIRA Jorge (director)
  • Board composition, CEREIJIDO FERREIRA Jorge (director)
  • Board composition, VACCARONE Valério Giovanni (director)
  • Board composition, TOMKINS Stephen Close (director)
16-05
NBB filing Annual accounts filed
fiscal year 2022 · full schema
30-03
State Gazette act Permanent representative: Halmar De Rooij
Mandate compensation · Power of attorney4 facts ▸
  • Board meeting, 19-12-2022
  • Permanent representative, Halmar De Rooij (représentant permanent de la succursale néerlandaise)
  • Mandate compensation, Halmar De Rooij
  • Power of attorney, Halmar De Rooij
21-03
State Gazette act Resignations: Giovanni Marco Levrino (director) and Alessandro Marengo (director)
Appointments: Valerio Giovanni Vaccarone (director) and Stephen Close Tomkins (director) · Director discharge · Mandate compensation15 facts ▸
  • General meeting, 22-12-2022
  • Director resignation, Giovanni Marco Levrino (director)
  • Director resignation, Alessandro Marengo (director)
  • Director discharge, Giovanni Marco Levrino
  • Director discharge, Alessandro Marengo
  • Director appointment, Valerio Giovanni Vaccarone (director)
  • Director appointment, Stephen Close Tomkins (director)
  • Mandate compensation, Valerio Giovanni Vaccarone
  • Mandate compensation, Stephen Close Tomkins
  • Board composition, Georges Pazzaglia (director)
  • Board composition, Valerio Giovanni Vaccarone (director)
  • Board composition, Stephen Close Tomkins (director)
  • +3 further facts in this act
27-01
State Gazette act Resignations & appointments
Power of attorney · Mandate term · Power of substitution35 facts ▸
  • Board meeting, 29-07-2022
  • Power of attorney, Georges Pazzaglia
  • Power of attorney, Damien Mannaert
  • Power of attorney, Teresa Cervino
  • Power of attorney, Fabrizio Momblano
  • Power of attorney, Fernando Ariel Davico
  • Power of attorney, Stephen Close Tomkins
  • Mandate term, Jusqu'à la fin du terme de l'emploi des mandataires spéciaux
  • Power of attorney, Michel Bonne
  • Power of attorney, Sarah Arens
  • Power of attorney, Sophie Ceulemans
  • Power of attorney, Edwige Jamotte
  • +23 further facts in this act
2022
30-05
State Gazette act Reappointments: Georges Pazzaglia (director) and PricewaterhouseCoopers Reviseurs d'Entreprises - PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
Permanent representative: Griet Helsen · Mandate compensation · Power of attorney13 facts ▸
  • General meeting, 20-04-2022
  • Director reappointment, Georges Pazzaglia (director)
  • Mandate compensation, Georges Pazzaglia
  • Board composition, Georges Pazzaglia (director)
  • Board composition, Giovanni Levrino (director)
  • Board composition, Alessandro Marengo (director)
  • Auditor reappointment, PricewaterhouseCoopers Reviseurs d'Entreprises - PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Griet Helsen
  • Power of attorney, Michel Bonne
  • Power of attorney, Vincent Reijns
  • Power of attorney, Sophie Ceulemans
  • Power of attorney, Edwige Jamotte
  • +1 further facts in this act
16-05
NBB filing Annual accounts filed
fiscal year 2021 · full schema
08-02
State Gazette act Permanent representative: Griet Helsen
Power of attorney3 facts ▸
  • General meeting, 20-12-2021
  • Permanent representative, Griet Helsen
  • Power of attorney, Michel Bonne
2021
05-05
NBB filing Annual accounts filed
fiscal year 2020 · full schema
19-03
State Gazette act Appointment: Alessandro Marengo (director)
Mandate compensation · Power of attorney11 facts ▸
  • General meeting, 01-03-2021
  • Director appointment, Alessandro Marengo (director)
  • Mandate compensation, Alessandro Marengo
  • Board composition, Georges Pazzaglia (director)
  • Board composition, Giovanni Marco Levrino (director)
  • Board composition, Alessandro Marengo (director)
  • Power of attorney, Michel Bonne
  • Power of attorney, Hannelore Matthys
  • Power of attorney, Alicia Cauwenbergh
  • Power of attorney, Vincent Reijns
  • Power of attorney, Edwige Jamotte
2020
30-10
State Gazette act Resignation: Marco Minolfo (director)
Appointment: Giovanni Marco Levrino (director) · Director discharge · Mandate compensation10 facts ▸
  • General meeting, 09/10/2020
  • Director resignation, Marco Minolfo (director)
  • Director discharge, Marco Minolfo
  • Director appointment, Giovanni Marco Levrino (director)
  • Mandate compensation, Giovanni Marco Levrino
  • Board composition, Georges Pazzaglia (director)
  • Board composition, Giovanni Marco Levrino (director)
  • Power of attorney, Michei Bonne
  • Power of attorney, Hannelore Matthys
  • Power of attorney, Alicia Cauwenbergh
24-09
State Gazette act Resignation: Benoit Traineau (director)
Director discharge · Power of attorney8 facts ▸
  • General meeting, 27-08-2020
  • Director resignation, Benoit Traineau (director)
  • Director discharge, Benoit Traineau
  • Board composition, Georges Pazzaglia (director)
  • Board composition, Marco Miriolfo (director)
  • Power of attorney, Michel Bonne
  • Power of attorney, Harinelore Matthys
  • Power of attorney, Alicia Cauwenbergh
14-05
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
14-08
State Gazette act Reappointment: PwC Reviseurs d'Entreprises SCRL (statutory auditor)
Permanent representatives: David Vanhelmont and Thomas Meurice4 facts ▸
  • General meeting, 25-07-2019
  • Auditor reappointment, PwC Reviseurs d'Entreprises SCRL
  • Permanent representative, David Vanhelmont
  • Permanent representative, Thomas Meurice
25-04
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
13-06
State Gazette act Resignation: Fabio Piazzalunga (director)
Appointment: Marco Minolfo (director) · Director discharge · Mandate compensation9 facts ▸
  • General meeting, 18-04-2018
  • Director resignation, Fabio Piazzalunga (director)
  • Director discharge, Fabio Piazzalunga
  • Director appointment, Marco Minolfo (director)
  • Mandate compensation, Marco Minolfo
  • Board composition, Georges Pazzaglia (director)
  • Board composition, Benoist Traineau (director)
  • Board composition, Marco Minolfo (director)
  • Board composition, Sarah Arens (director)
15-05
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
17-05
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
01-07
State Gazette act Appointment: SCCRL PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor)
Permanent representative: David Varihelmont3 facts ▸
  • General meeting, 13/06/2016
  • Auditor appointment, SCCRL PricewaterhouseCoopers Réviseurs d'Entreprises (statutory auditor)
  • Permanent representative, David Varihelmont
25-05
State Gazette act Reappointment: Georges Pazzaglia (director)
Appointments: Fabio Piazzalunga (director) and Benoist Traineau (director)7 facts ▸
  • General meeting, 20-04-2016
  • Director reappointment, Georges Pazzaglia (director)
  • Director appointment, Fabio Piazzalunga (director)
  • Director appointment, Benoist Traineau (director)
  • Board composition, Georges Pazzaglia (director)
  • Board composition, Fabio Piazzalunga (director)
  • Board composition, Benoist Traineau (director)
2015
12-08
State Gazette act Resignations & appointments
Power of attorney2 facts ▸
  • Board meeting, 21-07-2015
  • Power of attorney, Georges Pazzaglia
2012
09-05
State Gazette act Appointment: Luigi De Angelis (director)
Approval · Director discharge · Mandate compensation8 facts ▸
  • General meeting, 18-04-2012
  • Approval, 31-12-2011
  • Director discharge, DiaSorin SA/NV
  • Director appointment, Luigi De Angelis (director)
  • Mandate compensation, Luigi De Angelis
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
2011
23-12
State Gazette act Resignation: Andrea Senaldi (director)
Appointment: Luigi De Angelis (director) · Mandate compensation4 facts ▸
  • Board meeting, 14-11-2011
  • Director resignation, Andrea Senaldi (director)
  • Director appointment, Luigi De Angelis (director)
  • Mandate compensation, Luigi De Angelis
2010
10-12
State Gazette act Reappointments: Andrea Senaldi, Chen Even and 2 others
Resignation: Marc Lammens (director) · Appointment: Georges Léon Pazzaglia (director) · Power of attorney18 facts ▸
  • General meeting, 21-04-2010
  • Director reappointment, Andrea Senaldi (director)
  • Director reappointment, Chen Even (director)
  • Auditor reappointment, Deloitte & Partners
  • Director reappointment, Marc Lammens (managing director)
  • General meeting, 08-11-2010
  • Board meeting, 10-11-2010
  • Director resignation, Marc Lammens (director)
  • Director appointment, Georges Léon Pazzaglia (director)
  • Board composition, Andrea Senaldi (director)
  • Board composition, Chen Even (director)
  • Board composition, Georges Léon Pazzaglia (director)
  • +6 further facts in this act
2007
05-02
State Gazette act Resignations: Antonio BONIOLO (director) and Carlo ROSA (director)
Appointment: Andrea SENALDI (director) · Mandate compensation · Statutes amendment11 facts ▸
  • General meeting, 15-12-2006
  • Director resignation, Antonio BONIOLO (director)
  • Director resignation, Carlo ROSA (director)
  • Director appointment, Andrea SENALDI (director)
  • Board composition, Andrea SENALDI (director)
  • Board composition, Chen EVEN (director)
  • Board composition, Marc LAMMENS (administrateur délégué & directeur général)
  • Mandate compensation, Andrea SENALDI
  • Mandate compensation, Chen EVEN
  • Mandate compensation, Marc LAMMENS
  • Statutes amendment
2006
04-07
State Gazette act Capital & shares · Statutes amendment
2 facts ▸
  • General meeting, 15-06-2006
  • Statutes amendment
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
30 of 30 acts read

Directors · office · real estate

Directors
3 directors, 1 in day-to-day management, no change since 2026

Board 3

Barbara Rocchi
Director · since 15-05-2024
Current
Romuald Courtade
Director · since 24-04-2026
Current
Matteo Lombardi
Director · since 22-05-2026
Current
3 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Luigi De Angelis
Director · since 14-11-2011
Not recently confirmed
Benoist Traineau
Director · since 20-04-2016
Not recently confirmed
Chen Even
Director
Not recently confirmed

Day-to-day management 1

Romuald Courtade
Managing director · since 24-04-2026
Current
1 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Marc Lammens
Managing director
Not recently confirmed

Statutory auditor 1

PricewaterhouseCoopers Reviseurs d'Entreprises
Statutory auditor · since 01-07-2016 · perm. rep.: Thomas Meurice
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 1996
seat establishment The establishment unit on the map
Ground area
6,188 m²
Building footprint
700 m²
Volume, LiDAR
10,314 m³
Parcel 21306D0299/00C003, Brussels · tallest building 18.8 m, ±5 floors. Linked by address, not a title deed.
33 companies at this address See who is registered here
1 establishment unit
Diasorin
Paapsemlaan 11, 1070 AnderlechtNACE 5146002
since 19962.079.711.771
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21306D0299/00C003 Brussels 6,188 m² 1 · 700 m² 18.8 m · 5 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

24 people since 2006, 8 in office
Show
  • Board
  • Day-to-day management
  • Permanent representative
  • Statutory auditor
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Barbara Rocchi
  • Director, from 15-05-2024 to date
Romuald Courtade
  • Director, from 24-04-2026 to date
  • Managing director, from 24-04-2026 to date
Matteo Lombardi
  • Director, from 22-05-2026 to date
PricewaterhouseCoopers Reviseurs d'Entreprises
  • Statutory auditor, from 01-07-2016 to date
Chen Even
  • Director, already before 10-12-2010 not ended, last confirmed 10-12-2010
Luigi De Angelis
  • Director, from 14-11-2011 not ended, last confirmed 09-05-2012
Benoist Traineau
  • Director, from 20-04-2016 not ended, last confirmed 25-05-2016
Marc Lammens
  • Director, until 21-04-2010
  • Managing director, until 21-04-2010
  • Directeur général, until 21-04-2010
  • Managing director, already before 10-12-2010 not ended, last confirmed 10-12-2010
Valerio Giovanni Vaccarone
  • Director, from 31-12-2022 to 22-05-2026
CEREIJIDO FERREIRA Jorge
  • Director, from 04-10-2023 to 24-04-2026
  • Managing director, from 04-10-2023 to 24-04-2026
Stephen Close Tomkins
  • Director, from 31-12-2022 to 12-04-2024
CEREIJIDO FERREIRA Jorge
  • Représentant permanent de la succursale néerlandaise, from 04-10-2023 ended, last mentioned 20-11-2023
PAZZAGLIA Georges Léon
  • Director, from 01-01-2011 to 04-10-2023
  • Managing director, from 01-01-2011 to 04-10-2023
PAZZAGLIA Georges Léon
  • Représentant légal (branch manager) de la succursale néerlandaise, from 01-01-2011 to 04-10-2023
Alessandro Marengo
  • Director, from 01-03-2021 to 31-12-2022
Giovanni Marco Levrino
  • Director, from 01-10-2020 to 31-12-2022
Marco Minolfo
  • Director, from 18-04-2018 to 30-10-2020
Benoit Traineau
  • Director, until 27-08-2020
Fabio Piazzalunga
  • Director, from 20-04-2016 to 18-04-2018
DELOITTE & PARTNERS
  • Auditor, from 21-04-2010 to 01-07-2016
Andrea SENALDI
  • Director, from 15-12-2006 to 14-11-2011
Marc Lammens
  • Représentant légal (branch manager) de la succursale néerlandaise, until 21-04-2010
Antonio BONIOLO
  • Director, until 15-12-2006
Carlo ROSA
  • Director, until 15-12-2006
See the board, name and seat on a given date →

Articles of association

Purpose
L’importation, l’exportation, la vente en Belgique, la mise au point, l’installation et l’entretien d’installations d’appareils électromédicaux, d’équipements pour soins de santé…
Full purpose

L’importation, l’exportation, la vente en Belgique, la mise au point, l’installation et l’entretien d’installations d’appareils électromédicaux, d’équipements pour soins de santé, appareillages de laboratoires et scientifiques, de produits pour analyse clinique « in vitro », « in vivo » et accessoires, matériels consommables à usage biomédical et tout autre.

Power of attorney
Romuald Courtade
6 more provisions on this in the deed

Structure & network

Owners and holdings

1 owner

Chain of control

  1. Diasorin S.p.AIT 100%
  2. Diasorin

Highest known parent: Diasorin S.p.A (Italy). The sources do not say who stands above it.

Owners 1

Holdings 0

The accounts to 31-12-2025 list no holdings, and no other source names one.

According to the 2025 annual accounts of Diasorin and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

1 connected company
Depth

The connected companies are in the list below.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.
Linked via shared directors
WERFEN
Shared director
→

Capital and shareholders

Capital over the years
  1. 18-10-2023 Capital stated in the act · 1,674,000 EUR · 250 shares

Similar companies · same sector, comparable size

Of 10,428 companies in this sector we hold annual accounts for 885. 208 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPublic limited company
Founded17-12-1996
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
86995Nutrition and dietetics services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0459475142

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.